Preparation method of high-purity rocuronium bromide
CN109596728A
A kind of measuring method of acarbose tablet dissolution
CN109574940A
A kind of degradation impurity and its preparation, detection method and application of erlotinib Hydrochloride
CN108164521A
A kind of Parecoxib Sodium degradation impurity and its preparation, detection method and application
CN108299331A
A kind of Parecoxib Sodium light degradation impurity and its preparation, detection method and application
CN107703227A
A kind of high-efficiency liquid chromatography method for detecting of dolasetron mesilate chiral isomer
CN104610359A
Key intermediate for preparing tedizolid phosphate, and preparation method of key intermediate
CN104523582A
Stable terbutaline sulfate injection and preparation process thereof
CN104352465A
Prucalopride succinate pharmaceutical composition free of silicon dioxide and preparation method of prucalopride succinate pharmaceutical composition
CN104352464A
Gefitinib pharmaceutical composition free from surface active agent and preparation method thereof
CN104478809A
Levosimendan impurity and preparation and detection methods thereof
CN104367561A
Preparation method of bezoar ursodesoxycholic acid preparation
CN104447579A
Impurity of erlotinib hydrochloride as well as preparation method and detection method thereof
CN104288114A
Erlotinib hydrochloride pharmaceutical composition without containing surfactant
CN104288154A
Favipiravir pharmaceutical composition containing different particle size ranges
CN104277005A
Preparation method of crystal form of gefitinib Form 1
CN104230816A
Levosimendan potential genotoxic impurity as well as preparation and detection methods thereof
CN102875544A
Preparation technology of solifenacin succinate
CN102180878A
Dolasetron isomer or salt thereof, preparation method for the Dolasetron isomer or salt thereof and application of the Dolasetron isomer or salt thereof
CN102183589A
Method for detecting contents of dolasetron isomer and salt thereof
